Development of EBV-Positive T-cell Lymphoma Following Infection of Peripheral Blood T Cells with EBV

References

• Straus S. E., Cohen J. I., Tosato G., et al. NIH conference. Epstein‐Barr virus infections: biology, pathogenesis, and management. Ann. Intern. Med. 1993; 118: 45–58
   PubMed Web of Science ®Google Scholar
• Young L. S., Dawson C. W., Clark D., et al. Epstein‐Barr virus gene expression in nasopharyngeal carcinoma. J. Gen. Virol. 1988; 69: 1051–1065
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton‐Dutoit S. J., Rowe M., et al. Expression of Epstein‐Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320–322
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Chen Y. Y., Liu X. F., et al. Epstein‐Ban virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am. J. Parhol. 1991; 139: 1259–1265
   Web of Science ®Google Scholar
• McClain K. L., Leach C. T., Jenson H. B., et al. Association of Epstein‐Barr virus with leiomyosarcomas in young people with AIDS. N. Engl. J. Med. 1995; 332: 12–18
   PubMed Web of Science ®Google Scholar
• Lee E. S., Locker J., Nalesnik M., et al. The association of Epstein‐Barr virus with smooth‐muscle tumors occumng after organ transplantation. N. Engl. J. Med. 1995; 332: 19–25
   PubMed Web of Science ®Google Scholar
• Shibata D., Tokunaga M., Uemura Y., et al. Association of Epstein‐Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma‐like carcinoma. Am. J. Pathol. 1991; 139: 469–474
   PubMed Web of Science ®Google Scholar
• Imai S., Koizumi S., Sugiura M., et al. Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein‐Barr virus latent infection protein. Proc. Natl. Acad. Sci. 1994; 91: 9131–9135
   PubMed Web of Science ®Google Scholar
• Labrecque L. G., Barnes D. M., Fentiman I. S., et al. Epstein‐Barr virus in epithelial cell tumors: A breast cancer study. Cancer Res. 1995; 55: 39–45
   PubMed Web of Science ®Google Scholar
• Mori M., Kurozumi H., Akagi K., et al. Monoclonal proliferation of T cells containing Epstein‐Barr virus in fatal mononucleosis. N. Engl. J. Med. 1992; 327: 58
   PubMed Web of Science ®Google Scholar
• Kikuta H., Taguchi Y., Tomizawa K., et al. Epstein‐Barr virus genome‐positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki‐like disease. Nature 1988; 333: 455–457
   PubMed Web of Science ®Google Scholar
• Ishihara S., Tawa A., Yumura‐Yagi K., et al. Clonal T‐cell lymphoproliferation containing Epstein‐Barr (EB) virus DNA in a patient with chronic active EB virus infection. Jpn. J. Cancer Res. 1989; 80: 99–101
   PubMedGoogle Scholar
• Harabuchi Y., Yamanaka N., Kataura A., et al. Epstein‐Barr virus in nasal T‐cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 128–130
   PubMed Web of Science ®Google Scholar
• Jaffe E. S. Nasal and nasal‐type T/NK cell lym‐phoma: A unique form of lymphoma associated with the Epstein‐Barr virus. Histoparhol. 1995; 27: 581–583
   PubMed Web of Science ®Google Scholar
• Jones J. F., Shurin S., Abramowsky C., et al. T‐cell lymphomas containing Epstein‐Barr viral DNA in patients with chronic Epstein‐Barr virus infections. N. Engl. J. Med. 1988; 318: 733–741
   PubMed Web of Science ®Google Scholar
• Bonagura V. R., Katz B. Z., Edwards B. L., et al. Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA+ T‐cell lymphoma containing linear, EBV DNA. Clin. Immunol. Immunopathol. 1990; 57: 32–44
   PubMedGoogle Scholar
• Su I. J., Hsieh H. C., Lin K. H., et al. Aggressive peripheral T‐cell lymphomas containing Epstein‐Ban viral DNA: A clinicopathologic and molecular analysis. Blood 1991; 77: 799–808
   PubMed Web of Science ®Google Scholar
• Zhou X. G., Hamilton‐Dutoit S. J., Yan Q. H., et al. High frequency of Epstein‐Barr virus in Chinese peripheral T‐cell lymphoma. Histopathol. 1994; 24: 115–122
   PubMed Web of Science ®Google Scholar
• Tobi M., Morag A., Ravid Z., et al. Prolonged atypical illness associated with serological evidence of persistent Epstein‐Ban virus infection. Lancet 1982; 1: 61–63
   PubMed Web of Science ®Google Scholar
• Rickinson A. B. Chronic, symptomatic Epstein‐Barr virus infection. Immunol. Today 1986; 7: 13–14
   PubMedGoogle Scholar
• Kawa‐Ha K., Ishihara S., Ninomiya T., et al. CD3‐egative lymphoproliferative disease of granular lymphocytes containing Epstein‐Barr viral DNA. J. Clin. Invest. 1989; 84: 51–55
   PubMed Web of Science ®Google Scholar
• Fukunaga Y., Asano T., Takehana J., et al. CD3‐e‐gative lymphoproliferative disease of granular lymphocytes in a girl with an unusual pattern of anti‐Epstein‐Barr virus antibodies. Eu: J. Pediatr 1994; 153: 894–897
   PubMed Web of Science ®Google Scholar
• Kanegane H., Wada T., Nunogami K., et al. Chronic persistent Epstein‐Ban infection of natural killer cells and B cells associated with granular lymphocytes expansion. Brit. J. Haematol. 1996; 95: 116–122
   PubMed Web of Science ®Google Scholar
• Kanegane H., Bhatia K., Gutierrez M., et al. A syndrome of peripheral blood T‐cell infection with Epstein‐Barr virus (EBV) followed by EBV‐positive T‐cell lymphoma. Blood 1998; 91: 2085–2091
   PubMed Web of Science ®Google Scholar
• Hironaka T., Nagasaki M., Morikawa S., et al. Detection of Epstein‐Barr virus transcripts in chemically or immunologically activated cells and in a null cell‐line (HLN‐STL‐C) by in situ hybridization with alkaline phos‐phatase‐linked oligonucleotide probes. J. Virol. Methods 1993; 44: 141–154
   PubMed Web of Science ®Google Scholar
• Bhatia K., Raj A., Gutierrez M. I., et al. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphoma. Oncogene 1996; 13: 177–181
   PubMed Web of Science ®Google Scholar
• Gutierrez M. I., Raj A., Spangler G., et al. Sequence variations in EBNA‐1 may dictate restriction of tissue distribution of Epstein‐Barr virus in normal and tumor cells. J. Gen. Virol. 1997; 78: 1663–1670
   PubMed Web of Science ®Google Scholar
• Snudden D. K., Smith P. R., Lai D., et al. Alterations in the structure of the EBV nuclear antigen, EBNA‐I, in epithelial cell tumors. Oncogene 1995; 10: 1545–1552
   PubMed Web of Science ®Google Scholar
• Wrightham M. N., Stewart J. P., Janjua N. J., et al. Antigenic and sequence variation in the C‐terminal unique domain of the Epstein‐Barr virus nuclear antigen EBNA‐I. Virol. 1995; 208: 521–530
   PubMed Web of Science ®Google Scholar